Prophylactic treatment of bronchial asthma with theophylline, disodium cromoglycate and choline--a clinical, physiological and biochemical assessment.
D000328:Adult; D001249:Asthma / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D002794:Choline / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D005260:Female; D005652:Functional Residual Capacity; D006801:Humans; D008297:Male; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000097:blood; D010743:Phospholipids / Q000097:blood; D011897:Random Allocation; D012115:Residual Volume; D013806:Theophylline / Q000627:therapeutic use*
D008076:Cholesterol, HDL; D010743:Phospholipids; D002784:Cholesterol; D013806:Theophylline; D007862:Phosphatidylcholine-Sterol O-Acyltransferase; D002794:Choline; D004205:Cromolyn Sodium